NetworkNewsBreaks – EVIO, Inc. (EVIO) Posts Fisc
Post# of 2022
(Total Views: 244)
Posted On: 05/17/2018 6:07:19 PM
NetworkNewsBreaks – EVIO, Inc. (EVIO) Posts Fiscal Q2 2018 Financial Results
EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, recently announced financial and operating results for the quarter and six months ended March 31, 2018. Among other highlights, the company reported revenue for the second quarter of $732,311, a decrease of $56,415 or 12.1% from the second quarter last year. Revenue from the six months ending March 31, 2018, however, was $1,679,176, an increase of $177,997 or 11.9% from the same period in 2017. “EVIO’s second quarter focused greatly on broadening the company’s portfolio. With our recent private placement of $5.973 million, we expanded the company’s footprint by acquiring additional labs, namely in California, a market that we have identified as having unparalleled potential,” EVIO CEO William Waldrop stated in the news release. “We expect the state of California to enforce mandated compliance testing by July 1, 2018. With operational facilities in both Humboldt and Berkeley and the goal of further expansion into the state, we feel like EVIO is well-positioned to meet California’s demand for cannabis testing. Another significant milestone was our entrance into the Canadian market and launched EVIO Canada with the acquisition of Keystone Labs ahead of the country’s legalization of adult recreational use this summer.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, recently announced financial and operating results for the quarter and six months ended March 31, 2018. Among other highlights, the company reported revenue for the second quarter of $732,311, a decrease of $56,415 or 12.1% from the second quarter last year. Revenue from the six months ending March 31, 2018, however, was $1,679,176, an increase of $177,997 or 11.9% from the same period in 2017. “EVIO’s second quarter focused greatly on broadening the company’s portfolio. With our recent private placement of $5.973 million, we expanded the company’s footprint by acquiring additional labs, namely in California, a market that we have identified as having unparalleled potential,” EVIO CEO William Waldrop stated in the news release. “We expect the state of California to enforce mandated compliance testing by July 1, 2018. With operational facilities in both Humboldt and Berkeley and the goal of further expansion into the state, we feel like EVIO is well-positioned to meet California’s demand for cannabis testing. Another significant milestone was our entrance into the Canadian market and launched EVIO Canada with the acquisition of Keystone Labs ahead of the country’s legalization of adult recreational use this summer.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)